Furthermore, the authors observed that in transgenic mouse-derived bone marrow (BM) precursors with chimeric AD amyloid, that is, TLR2-deficient BM-derived microglia, more M2 microglia were activated than M1 microglia, which reduces neuroinflammation. The gene discussed is TLR2; the disease is Alzheimer disease.